ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Controversial Dr. Rajika Medencica Sued By Patient; Hilton Head hospital Reviews His Practices

April 30, 1993

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989

Data On CT Screening For Lung Cancer Raises Questions About DOD Program

April 23, 2010

NCI Proposes Moving Organ Systems coordinating Center Activities In House, Dispersing Grants

October 16, 1987

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009